Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion type Assertion NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_head.
- NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion description "[In clinical samples, EphA5 methylation was detected in 64.1% (75/117) of breast tumors and 28.2% (33/117) of paired normal tissues (P < .001), which was associated with higher tumor grade (P = .024), lymph node metastasis (P = .004), and progesterone receptor-negative status (P = .008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_provenance.
- NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion evidence source_evidence_literature NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_provenance.
- NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion SIO_000772 19733895 NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_provenance.
- NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion wasDerivedFrom befree-2016 NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_provenance.
- NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_assertion wasGeneratedBy ECO_0000203 NP761515.RAB2Ma559FZqvhE64wXHDe2aqazNWZ7kQX6x9LR8rbNbE130_provenance.